Indeed, FSP1 is highly expressed in KEAP1 mutant lung cancers, which have high NRF2 levels due to impaired proteasomal clearance and are resistant to GPX4 inhibition [98]. This evidence concerns the gene KEAP1 and lung carcinoma.